Management tracks

Immunotherapy company Advaxis Inc. (NASDAQ:ADXS) said President and CEO Daniel O’Connor resigned. CBO Anthony Lombardo will be interim CEO while the company seeks a replacement.

Rare disease company OxThera AB (Stockholm, Sweden) named Matthew Gantz CEO. He succeeds Elisabeth Lindner, who will be the company's COO. Gantz was EVP at the U.S. division of BTG plc (LSE:BTG)...